Another research group reported that low expression of miR-340 is associated with poor prognosis in colorectal cancer and demonstrated that pre-miR-340 administration inhibited growth of colon cancer cells and suppressed c-Met expression in vitro. Here, MET is linked to malignant colon neoplasm.